期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CardioRenal Medicine LetPub Score 5.1
50 ratings
Rate
Reputation 6.3 Influence 3.6 Speed 6.9 | ||||||||||||||||||||||||
期刊簡稱 | CARDIORENAL MED | ||||||||||||||||||||||||
ISSN | 1664-3828 | ||||||||||||||||||||||||
E-ISSN | 1664-5502 | ||||||||||||||||||||||||
h-index | 17 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 8.30%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.karger.com/Journal/Home/254695 | ||||||||||||||||||||||||
在線稿件提交 | http://www.karger.com/Journal/Guidelines/254695 | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | S. Karger AG | ||||||||||||||||||||||||
主題領域 | CARDIAC & CARDIOVASCULAR SYSTEMS | ||||||||||||||||||||||||
出版國/地區 | SWITZERLAND | ||||||||||||||||||||||||
發行頻率 | |||||||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||||||
每年文章數 | 31每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 100.00% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1664-3828%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[CardioRenal Medicine] 的評論 | 撰寫評論 |
作者: ZS2022 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-05-24 16:50:06 評論於 Posted on November 23, 2022, and returned with comments from 2 reviewers on February 13, 2023. One of the reviewers paid close attention and provided very constructive suggestions for the article's structure, presentation of results, readability, and use of professional terminology. After resubmission on March 16, a suggestion for minor revisions was given on March 27, and after returning on March 28, the article was accepted on May 24. The process took a total of 7 months. The chosen reviewers were highly professional, although the editorial department was a bit slow. Overall, everything else was fine, and there is hope for an improved ranking.(0) 讚! | ZS2022 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:56:09 評論於 The city where I grew up is known for its beautiful scenery and friendly people. I have so many fond memories of playing in the parks and walking along the river with my friends(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 10:04:34 評論於 Please be cautious with the use of abbreviations in the title, especially for abbreviations with multiple interpretations. Limit the use of abbreviations and if necessary, provide the full name in parentheses. Use recognized abbreviations whenever possible and avoid non-standard abbreviations(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 19:53:33 評論於 What kind of titles do reviewers generally prefer?(0) 讚! | Oswald Edie |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 11:40:30 評論於 Please translate the following passage into English and Japanese, and title them ":" and ":"(0) 讚! | 平原文波 |
作者: 百花腊月 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-10-13 17:38:48 評論於 Review speed: 6.0 | Submission hit rate: 5.0 Experience sharing: The review time is relatively long, 3 months, with strict requirements and high level of innovation(0) 讚! | 百花腊月 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us